AU1653100A - Use of diminazene-di-aceturate for treating malaria - Google Patents

Use of diminazene-di-aceturate for treating malaria

Info

Publication number
AU1653100A
AU1653100A AU16531/00A AU1653100A AU1653100A AU 1653100 A AU1653100 A AU 1653100A AU 16531/00 A AU16531/00 A AU 16531/00A AU 1653100 A AU1653100 A AU 1653100A AU 1653100 A AU1653100 A AU 1653100A
Authority
AU
Australia
Prior art keywords
aceturate
diminazene
treating malaria
malaria
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU16531/00A
Inventor
Alain-Jacques Bourdichon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU1653100A publication Critical patent/AU1653100A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Pyrane Compounds (AREA)

Abstract

The aim of the invention is to provide a substance which is suitable for treating malaria. To this end, the invention proposes the use of diminazene-di-aceturate and/or pentamidine.
AU16531/00A 1998-11-24 1999-11-23 Use of diminazene-di-aceturate for treating malaria Abandoned AU1653100A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19853944 1998-11-24
DE19853944A DE19853944A1 (en) 1998-11-24 1998-11-24 Use of diminazene diaceturate or pentamidine for treating malaria
PCT/EP1999/009026 WO2000030631A1 (en) 1998-11-24 1999-11-23 Use of diminazene-di-aceturate for treating malaria

Publications (1)

Publication Number Publication Date
AU1653100A true AU1653100A (en) 2000-06-13

Family

ID=7888691

Family Applications (1)

Application Number Title Priority Date Filing Date
AU16531/00A Abandoned AU1653100A (en) 1998-11-24 1999-11-23 Use of diminazene-di-aceturate for treating malaria

Country Status (5)

Country Link
EP (1) EP1220668B1 (en)
AT (1) ATE275949T1 (en)
AU (1) AU1653100A (en)
DE (2) DE19853944A1 (en)
WO (1) WO2000030631A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4926707B2 (en) 2003-08-22 2012-05-09 ダニスコ エイ／エス Encapsulated antibacterial material
GB2388581A (en) 2003-08-22 2003-11-19 Danisco Coated aqueous beads
ATE534389T1 (en) * 2007-10-05 2011-12-15 Univ Mons Hainaut BISBENZIMIDAZOLE AND ANTIMALARIA DRUGS
WO2011042565A2 (en) 2009-10-09 2011-04-14 Instituut Voor Tropische Geneeskunde Antiprotozoal activity

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU626033B2 (en) * 1988-10-25 1992-07-23 Government Of The United States Of America, As Represented By The Secretary Of The Army, The Methods for the treatment and prophylaxis of pneumocystis carinii pneumonia and other diseases and compounds and formulations for use in said methods

Also Published As

Publication number Publication date
EP1220668B1 (en) 2004-09-15
EP1220668A1 (en) 2002-07-10
ATE275949T1 (en) 2004-10-15
DE59910542D1 (en) 2004-10-21
WO2000030631A1 (en) 2000-06-02
DE19853944A1 (en) 2000-05-25

Similar Documents

Publication Publication Date Title
WO2002074293A3 (en) Methods for restoring cognitive function following systemic stress
SI0797439T1 (en) Use of pramipexole as a neuroprotective agent
ES2177810T3 (en) AEROGEL COATED SHEET.
AU2003247796A8 (en) Tampon applicator with improved fingergrip and method of making same
MXPA02011427A (en) Process for coating medical devices using super critical carbon dioxide.
ZA200007642B (en) Treatment of airborne microorganisms.
YU89503A (en) Use of osteopontin for the treatment and/or prevention of neurologic diseases
AU3717395A (en) Compositions for the treatment of skin disorders
AU6274299A (en) Inhibition of pak activation of raf-1
AU1697197A (en) Immunoconjugate for the treatment of aids
AU1653100A (en) Use of diminazene-di-aceturate for treating malaria
NZ320259A (en) Deodorizing preparations containing cationic biopolymers, aluminium hydrochlorate and esterase inhibitors
WO2004037168A3 (en) Treatment of pancreatitis with amylin
PL334524A1 (en) 3-aminocarbonyl/3-aminothiocarbonyl-substituted 2-benzoylcyclohexano-1,3-diones of herbicidal properties
AU6206698A (en) Isoflavone derivatives, processes for the preparation thereof and pharmac euticalcompositions containing them
AU2003274565A1 (en) Composition for the treatment of nasopharyngeal carcinoma and use thereof
EP0838461A3 (en) Substituted 2,3-aryl-benzothiophene compounds having estrogenic activity
IL139303A0 (en) Treatment of arthritis and other similar conditions
WO2003008595A3 (en) Novel oligoribonucleotide derivatives for the targeted inhibition of gene expression
MY140504A (en) Statin-mmp inhibitor combinations
EP1351680B8 (en) Use of anethole-dithiolethione for preventing and treating drug-induced tendon toxicity
AU3145400A (en) Preparation for the prevention and/or treatment of a tissue change of mesenchymal origin
WO2000027376A3 (en) Use of thiol compounds, oxidoreductases and/or hydrolases for the treatment of tinnitus, especially chronic tinnitus
WO2001005360A3 (en) Disinfecting shaving agent
AU3463200A (en) Santa character agent embodied on web on the basis of java/xml technology

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase